Gregory A. Demopulos, M.D.
Principal executive officer pay for Gregory A. Demopulos, M.D., by year and company, from pay-versus-performance disclosure. Every figure links to its source on the company page.
OMEROS CORP (OMER) FY2022–FY2025
Aligned: paid up as stock roseCAP $1,333,430→$17,583,391 while $100 invested went $35.15→$759.96
| Fiscal year | SCT total | Comp actually paid |
|---|---|---|
| FY2022 | $3.7M | $1.3M |
| FY2023 | $7.7M | $8.7M |
| FY2024 | $3.8M | $12.4M |
| FY2025 | $4.2M | $17.6M |
The company's "$100 invested" index ran $35.15 at FY2022 → $759.96 by FY2025 — an annualized return of 178.6%.
Track record
1 measurable tenure in the pay-versus-performance disclosure window. Best annualized TSR: 178.6%/yr at OMER ( FY2022–FY2025). See the CEO track-record ranking for context.